JAMA
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
By Thomas A. Wadden, Timothy Silleck Bailey, Liana K. Billings, Show 9 more authorsSTEP 3 Investigators
Randomised trial in 611 peopleInterventions
68 weeks, double-blind, placebo-controlled, multicentre, registered NCT03611582
